Yarrow Bioscience, Inc.
YARW· Nasdaq
Released Aug 12, 2022, before the open
10-Q filed Aug 12, 2022, 43 days after period end · 0001628280-22-022687
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $126.00K | $295.00K | $11.69M | $0.00 |
| Net Income | -$8.48M | -$19.92M | -$167.44M | -$18.99M |
| EPS Diluted |
Yarrow Bioscience, Inc. · CIK 1566044 · Engraved from SEC EDGAR
| -$2.63 |
| -$0.39 |
| -$4.83 |
| $2.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.